Logo of biochemjLink to Publisher's site
Biochem J. 1992 Dec 1; 288(Pt 2): 619–624.
PMCID: PMC1132055
PMID: 1334410

Characterization of noradrenaline-stimulated cyclic GMP formation in brain astrocytes in culture.


Cyclic GMP accumulation induced by noradrenaline in astrocyte-enriched primary cultures from rat cerebrum involves synthesis of NO, as evidenced by the competitive inhibition exerted by the NO synthase inhibitor NG-monomethyl-L-arginine (IC50 = 3 microM). Furthermore, the noradrenaline effect was potently inhibited by haemoglobin (IC50 = 25 nM) and potentiated by superoxide dismutase, indicating that NO synthesis and cyclic GMP formation may occur in different subsets of astrocytes. Investigation of the receptors implicated by using selective adrenoceptor agonists and antagonists indicates that about 75% of the NO-dependent noradrenaline response is mediated by alpha 1-adrenoceptors and the rest by beta-adrenoceptors, with no evidence for potentiating effects between the two receptor types. This noradrenaline effect appears to require Ca2+ entry, since it is strongly dependent on extracellular Ca2+ but is not affected by conditions that will abolish intracellular Ca2+ mobilization (incubation with neomycin or pretreatment with carbachol). Inhibition by pretreatment with pertussis toxin is in agreement with involvement of the alpha 1A-adrenoceptor subtype in this Ca(2+)-dependent effect. However, implication of an unknown alpha 1-adrenoceptor subtype cannot be disregarded, because a similar inhibition is exerted by the presumably selective alpha 1B- and alpha 1C-adrenoceptor blocking agent chloroethylclonidine. Treatment of the cultures with the protein kinase C activator phorbol 12-myristate 13-acetate inhibits to a great extent the noradrenaline-induced cyclic GMP formation.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Goldberg ND, Haddox MK. Cyclic GMP metabolism and involvement in biological regulation. Annu Rev Biochem. 1977;46:823–896. [PubMed]
  • Wood PL. Pharmacology of the second messenger, cyclic guanosine 3',5'-monophosphate, in the cerebellum. Pharmacol Rev. 1991 Mar;43(1):1–25. [PubMed]
  • Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 1988 Nov 24;336(6197):385–388. [PubMed]
  • Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed]
  • Knowles RG, Palacios M, Palmer RM, Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5159–5162. [PMC free article] [PubMed]
  • Förstermann U, Gorsky LD, Pollock JS, Schmidt HH, Heller M, Murad F. Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain. Biochem Biophys Res Commun. 1990 Apr 30;168(2):727–732. [PubMed]
  • Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A. 1990 Jan;87(2):682–685. [PMC free article] [PubMed]
  • Mayer B, John M, Böhme E. Purification of a Ca2+/calmodulin-dependent nitric oxide synthase from porcine cerebellum. Cofactor-role of tetrahydrobiopterin. FEBS Lett. 1990 Dec 17;277(1-2):215–219. [PubMed]
  • Förstermann U, Schmidt HH, Pollock JS, Sheng H, Mitchell JA, Warner TD, Nakane M, Murad F. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol. 1991 Oct 24;42(10):1849–1857. [PubMed]
  • Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991 Jun 27;351(6329):714–718. [PubMed]
  • Southam E, East SJ, Garthwaite J. Excitatory amino acid receptors coupled to the nitric oxide/cyclic GMP pathway in rat cerebellum during development. J Neurochem. 1991 Jun;56(6):2072–2081. [PubMed]
  • Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 1990 Oct 25;347(6295):768–770. [PubMed]
  • De Vente J, Bol JGJM, Berkelmans HS, Schipper J, Steinbusch HMW. Immunocytochemistry of cGMP in the Cerebellum of the Immature, Adult, and Aged Rat: the Involvement of Nitric Oxide. A Micropharmacological Study. Eur J Neurosci. 1990;2(10):845–862. [PubMed]
  • Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 1991 Feb;14(2):60–67. [PubMed]
  • Murphy S, Minor RL, Jr, Welk G, Harrison DG. Evidence for an astrocyte-derived vasorelaxing factor with properties similar to nitric oxide. J Neurochem. 1990 Jul;55(1):349–351. [PubMed]
  • Agulló L, García A. Norepinephrine increases cyclic GMP in astrocytes by a mechanism dependent on nitric oxide synthesis. Eur J Pharmacol. 1991 Apr 25;206(4):343–346. [PubMed]
  • Agulló L, García A. Different receptors mediate stimulation of nitric oxide-dependent cyclic GMP formation in neurons and astrocytes in culture. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1362–1368. [PubMed]
  • Agulló L, Picatoste F, García A. Histamine stimulation of cyclic AMP accumulation in astrocyte-enriched and neuronal primary cultures from rat brain. J Neurochem. 1990 Nov;55(5):1592–1598. [PubMed]
  • Brooker G, Harper JF, Terasaki WL, Moylan RD. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv Cyclic Nucleotide Res. 1979;10:1–33. [PubMed]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Martin W, Smith JA, White DG. The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor. Br J Pharmacol. 1986 Nov;89(3):563–571. [PMC free article] [PubMed]
  • Johnson RD, Minneman KP. Differentiation of alpha 1-adrenergic receptors linked to phosphatidylinositol turnover and cyclic AMP accumulation in rat brain. Mol Pharmacol. 1987 Mar;31(3):239–246. [PubMed]
  • Enkvist MO, Holopainen I, Akerman KE. Alpha-receptor and cholinergic receptor-linked changes in cytosolic Ca2+ and membrane potential in primary rat astrocytes. Brain Res. 1989 Oct 23;500(1-2):46–54. [PubMed]
  • Salm AK, McCarthy KD. Norepinephrine-evoked calcium transients in cultured cerebral type 1 astroglia. Glia. 1990;3(6):529–538. [PubMed]
  • Wilson KM, Minneman KP. Pertussis toxin inhibits norepinephrine-stimulated inositol phosphate formation in primary brain cell cultures. Mol Pharmacol. 1990 Aug;38(2):274–281. [PubMed]
  • Pearce B, Morrow C, Murphy S. Characteristics of phorbol ester- and agonist-induced down-regulation of astrocyte receptors coupled to inositol phospholipid metabolism. J Neurochem. 1988 Mar;50(3):936–944. [PubMed]
  • Surichamorn W, Forray C, el-Fakahany EE. Role of intracellular Ca2+ mobilization in muscarinic and histamine receptor-mediated activation of guanylate cyclase in N1E-115 neuroblastoma cells: assessment of the arachidonic acid release hypothesis. Mol Pharmacol. 1990 Jun;37(6):860–869. [PubMed]
  • Reiser G. Mechanism of stimulation of cyclic-GMP level in a neuronal cell line mediated by serotonin (5-HT3) receptors. Involvement of nitric oxide, arachidonic-acid metabolism and cytosolic Ca2+. Eur J Biochem. 1990 May 20;189(3):547–552. [PubMed]
  • Garthwaite J, Garthwaite G, Palmer RM, Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol. 1989 Oct 17;172(4-5):413–416. [PubMed]
  • Förstermann U, Gorsky LD, Pollock JS, Ishii K, Schmidt HH, Heller M, Murad F. Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol Pharmacol. 1990 Jul;38(1):7–13. [PubMed]
  • Aoki E, Semba R, Mikoshiba K, Kashiwamata S. Predominant localization in glial cells of free L-arginine. Immunocytochemical evidence. Brain Res. 1991 May 3;547(2):190–192. [PubMed]
  • Minneman KP, Johnson RD. Characterization of alpha-1 adrenergic receptors linked to [3H]inositol metabolism in rat cerebral cortex. J Pharmacol Exp Ther. 1984 Aug;230(2):317–323. [PubMed]
  • Kendall DA, Brown E, Nahorski SR. Alpha 1-adrenoceptor-mediated inositol phospholipid hydrolysis in rat cerebral cortex: relationship between receptor occupancy and response and effects of denervation. Eur J Pharmacol. 1985 Aug 7;114(1):41–52. [PubMed]
  • Atkinson BN, Minneman KP. Multiple adrenergic receptor subtypes controlling cyclic AMP formation: comparison of brain slices and primary neuronal and glial cultures. J Neurochem. 1991 Feb;56(2):587–595. [PubMed]
  • Schwartz JP. Catecholamine-mediated elevation of cyclic GMP in the rat C-6 glioma cell line. J Cyclic Nucleotide Res. 1976 Jul-Aug;2(4):287–296. [PubMed]
  • Bottenstein JE, de Vellis J. Regulation of cyclic GMP, cyclic AMP and lactate dehydrogenase by putative neurotransmitters in the C6 rat glioma cell line. Life Sci. 1978 Aug 28;23(8):821–834. [PubMed]
  • Vanecek J, Sugden D, Weller J, Klein DC. Atypical synergistic alpha 1- and beta-adrenergic regulation of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in rat pinealocytes. Endocrinology. 1985 Jun;116(6):2167–2173. [PubMed]
  • Ferrendelli JA, Kinscherf DA, Chang MM, Morgan JF. Comparison of the effects of biogenic amines on cyclic GMP and cycle AMP levels in mouse cerebellum in vitro. Brain Res. 1975 Jan 24;84(1):63–73. [PubMed]
  • MacVicar BA, Tse FW. Norepinephrine and cyclic adenosine 3':5'-cyclic monophosphate enhance a nifedipine-sensitive calcium current in cultured rat astrocytes. Glia. 1988;1(6):359–365. [PubMed]
  • Bowman CL, Kimelberg HK. Pharmacological properties of the norepinephrine-induced depolarization of astrocytes in primary culture: evidence for the involvement of an alpha 1-adrenergic receptor. Brain Res. 1987 Oct 13;423(1-2):403–407. [PubMed]
  • Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron. 1992 Jan;8(1):3–11. [PubMed]
  • Schwinn DA, Lomasney JW, Lorenz W, Szklut PJ, Fremeau RT, Jr, Yang-Feng TL, Caron MG, Lefkowitz RJ, Cotecchia S. Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. J Biol Chem. 1990 May 15;265(14):8183–8189. [PubMed]
  • Minneman KP, Atkinson B. Interaction of subtype-selective antagonists with alpha 1-adrenergic receptor-mediated second messenger responses in rat brain. Mol Pharmacol. 1991 Oct;40(4):523–530. [PubMed]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society